Sfoglia per Autore
Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia
2004-08-01 Venditti, A; DEL POETA, G; Maurillo, L; Buccisano, F; DEL PRINCIPE, Mi; Mazzone, C; Tamburini, A; Cox, C; Panetta, P; Neri, B; Ottaviani, L; Amadori, S
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia
2004-12-01 DEL PRINCIPE, Mi; DEL POETA, G; Venditti, A; Buccisano, F; Maurillo, L; Marini, R; Cox, M; Panetta, P; Suppo, G; Degan, M; Bruno, A; Gattei, V; Amadori, S
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia
2005-01-01 Noguera, Ni; LO COCO, F; Ammatuna, E; Zangrilli, D; Lavorgna, S; Divona, M; Buccisano, F; Amadori, S; Mecucci, C; Falini, B
Apoptosis and immaturity in acute myeloid leukemia
2005-02-01 DEL PRINCIPE, Mi; DEL POETA, G; Venditti, A; Buccisano, F; Maurillo, L; Mazzone, C; Bruno, A; Neri, B; Irno Consalvo, M; LO COCO, F; Amadori, S
Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling
2005-07-01 Zucchetto, A; Sonego, P; Degan, M; Bomben, R; Dal Bo, M; Russo, S; Attadia, V; Rupolo, M; Buccisano, F; DEL PRINCIPE, Mi; DEL POETA, G; Pucillo, C; Colombatti, A; Campanini, R; Gattei, V
Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy
2005-10-01 Niscola, P; DEL PRINCIPE, Mi; Maurillo, L; Venditti, A; Buccisano, F; Piccioni, D; Amadori, S; DEL POETA, G
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance
2005-10-20 Zucchetto, A; Sonego, P; Degan, M; Bomben, R; Dal Bo, M; Russo, S; Attadia, V; Rupolo, M; Buccisano, F; Steffan, A; DEL POETA, G; Pucillo, C; Colombatti, A; Campanini, R; Gattei, V
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia
2005-12-15 DEL POETA, G; DEL PRINCIPE, Mi; Consalvo, M; Maurillo, L; Buccisano, F; Venditti, A; Mazzone, C; Bruno, A; Gianní, L; Capelli, G; LO COCO, F; Cantonetti, M; Gattei, V; Amadori, S
O6-(4-Bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro
2006-01-01 Turriziani, Ma; Caporaso, Pb; Bonmassar, Lb; Buccisano, F; Amadori, S; Venditti, A; Cantonetti, M; D'Atri, Sb; Bonmassar, Ed
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.
2006-01-01 DEL PRINCIPE, Mi; DEL POETA, G; Buccisano, F; Maurillo, L; Venditti, A; Zucchetto, A; Marini, R; Niscola, P; Irno Consalvo, M; Mazzone, C; Ottaviani, L; Panetta, P; Bruno, A; Bomben, R; Suppo, G; Degan, M; Gattei, V; DE FABRITIIS, P; Cantonetti, M; LO COCO, F; DEL PRINCIPE, D; Amadori, S
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia.
2006-01-01 Buccisano, F; Maurillo, L; Gattei, V; DEL POETA, G; DEL PRINCIPE, Mi; Cox, M; Panetta, P; Consalvo, M; Mazzone, C; Neri, B; Ottaviani, L; Fraboni, D; Tamburini, A; LO COCO, F; Amadori, S; Venditti, A
Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia
2006-12-01 Buccisano, F; Maurillo, L; DEL POETA, G; Gattei, V; Amadori, S; Venditti, A
Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia
2006-12-01 DEL POETA, G; DEL PRINCIPE, Mi; Buccisano, F; Maurillo, L; Niscola, P; Venditti, A; Amadori, S
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow
2007-01-01 Maurillo, L; Buccisano, F; Spagnoli, A; DEL POETA, G; Panetta, P; Neri, B; DEL PRINCIPE, Mi; Mazzone, C; Consalvo, M; Tamburini, A; Ottaviani, L; Fraboni, D; Sarlo, C; DE FABRITIIS, P; Amadori, S; Venditti, A
Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia
2007-01-01 Caporaso, P; Turriziani, M; Venditti, A; Marchesi, F; Buccisano, F; Tirindelli, M; Alvino, E; Garbin, A; Tortorelli, G; Toppo, L; Bonmassar, E; D'Atri, S; Amadori, S
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR alpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study
2007-01-01 Baccarani, M; Cilloni, D; Rondoni, M; Ottaviani, E; Messa, F; Merante, S; Tiribelli, M; Buccisano, F; Testoni, N; Gottardi, E; De Vivo, A; Giugliano, E; Iacobucci, I; Paolini, S; Soverini, S; Rosti, G; Rancati, F; Astolfi, C; Pane, F; Saglio, G; Martinelli, G
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
2008-01-01 Gattei, V; Bulian, P; DEL PRINCIPE, Mi; Zucchetto, A; Maurillo, L; Buccisano, F; Bomben, R; Dal Bo, M; Luciano, F; Rossi, F; Degan, M; Amadori, S; DEL POETA, G
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.
2008-01-01 DEL POETA, G; DEL PRINCIPE, Mi; Buccisano, F; Maurillo, L; Capelli, G; Luciano, F; Perrotti, A; Degan, M; Venditti, A; DE FABRITIIS, P; Gattei, V; Amadori, S
SEQUENTIAL THERAPY WITH VAD, BORTEZOMIB AND CYCLOPHOSPHAMIDE AS INDUCTION THERAPY FOR MULTIPLE MYELOMA: A SEQUENTIAL PHARMACOLOGIC COMBINATION TO ACHIEVE COMPLETE REMISSIONS BEFORE STEM CELL TRANSPLANTATION
2008-01-01 Postorino, M; Pupo, L; Di Caprio, L; Campagna, S; Franceschini, L; Renzi, D; Rizzo, M; Gianni, L; Faccia, S; Cannarsa, R; Ales, M; Buccisano, F; Venditti, D; Cantonetti, M; Amadori, S
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.
2008-01-01 Stasi, R; Evangelista, M; Buccisano, F; Venditti, A; Amadori, S
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-ago-2004 | Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia | Venditti, A; DEL POETA, G; Maurillo, L; Buccisano, F; DEL PRINCIPE, Mi; Mazzone, C; Tamburini, A; Cox, C; Panetta, P; Neri, B; Ottaviani, L; Amadori, S | Articolo su rivista | |
| 1-dic-2004 | Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia | DEL PRINCIPE, Mi; DEL POETA, G; Venditti, A; Buccisano, F; Maurillo, L; Marini, R; Cox, M; Panetta, P; Suppo, G; Degan, M; Bruno, A; Gattei, V; Amadori, S | Articolo su rivista | |
| 1-gen-2005 | Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia | Noguera, Ni; LO COCO, F; Ammatuna, E; Zangrilli, D; Lavorgna, S; Divona, M; Buccisano, F; Amadori, S; Mecucci, C; Falini, B | Articolo su rivista | |
| 1-feb-2005 | Apoptosis and immaturity in acute myeloid leukemia | DEL PRINCIPE, Mi; DEL POETA, G; Venditti, A; Buccisano, F; Maurillo, L; Mazzone, C; Bruno, A; Neri, B; Irno Consalvo, M; LO COCO, F; Amadori, S | Articolo su rivista | |
| 1-lug-2005 | Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling | Zucchetto, A; Sonego, P; Degan, M; Bomben, R; Dal Bo, M; Russo, S; Attadia, V; Rupolo, M; Buccisano, F; DEL PRINCIPE, Mi; DEL POETA, G; Pucillo, C; Colombatti, A; Campanini, R; Gattei, V | Articolo su rivista | |
| 1-ott-2005 | Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy | Niscola, P; DEL PRINCIPE, Mi; Maurillo, L; Venditti, A; Buccisano, F; Piccioni, D; Amadori, S; DEL POETA, G | Articolo su rivista | |
| 20-ott-2005 | Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance | Zucchetto, A; Sonego, P; Degan, M; Bomben, R; Dal Bo, M; Russo, S; Attadia, V; Rupolo, M; Buccisano, F; Steffan, A; DEL POETA, G; Pucillo, C; Colombatti, A; Campanini, R; Gattei, V | Articolo su rivista | |
| 15-dic-2005 | The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia | DEL POETA, G; DEL PRINCIPE, Mi; Consalvo, M; Maurillo, L; Buccisano, F; Venditti, A; Mazzone, C; Bruno, A; Gianní, L; Capelli, G; LO COCO, F; Cantonetti, M; Gattei, V; Amadori, S | Articolo su rivista | |
| 1-gen-2006 | O6-(4-Bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro | Turriziani, Ma; Caporaso, Pb; Bonmassar, Lb; Buccisano, F; Amadori, S; Venditti, A; Cantonetti, M; D'Atri, Sb; Bonmassar, Ed | Articolo su rivista | |
| 1-gen-2006 | Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. | DEL PRINCIPE, Mi; DEL POETA, G; Buccisano, F; Maurillo, L; Venditti, A; Zucchetto, A; Marini, R; Niscola, P; Irno Consalvo, M; Mazzone, C; Ottaviani, L; Panetta, P; Bruno, A; Bomben, R; Suppo, G; Degan, M; Gattei, V; DE FABRITIIS, P; Cantonetti, M; LO COCO, F; DEL PRINCIPE, D; Amadori, S | Articolo su rivista | |
| 1-gen-2006 | The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia. | Buccisano, F; Maurillo, L; Gattei, V; DEL POETA, G; DEL PRINCIPE, Mi; Cox, M; Panetta, P; Consalvo, M; Mazzone, C; Neri, B; Ottaviani, L; Fraboni, D; Tamburini, A; LO COCO, F; Amadori, S; Venditti, A | Articolo su rivista | |
| 1-dic-2006 | Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia | Buccisano, F; Maurillo, L; DEL POETA, G; Gattei, V; Amadori, S; Venditti, A | Articolo su rivista | |
| 1-dic-2006 | Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia | DEL POETA, G; DEL PRINCIPE, Mi; Buccisano, F; Maurillo, L; Niscola, P; Venditti, A; Amadori, S | Articolo su rivista | |
| 1-gen-2007 | Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow | Maurillo, L; Buccisano, F; Spagnoli, A; DEL POETA, G; Panetta, P; Neri, B; DEL PRINCIPE, Mi; Mazzone, C; Consalvo, M; Tamburini, A; Ottaviani, L; Fraboni, D; Sarlo, C; DE FABRITIIS, P; Amadori, S; Venditti, A | Articolo su rivista | |
| 1-gen-2007 | Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia | Caporaso, P; Turriziani, M; Venditti, A; Marchesi, F; Buccisano, F; Tirindelli, M; Alvino, E; Garbin, A; Tortorelli, G; Toppo, L; Bonmassar, E; D'Atri, S; Amadori, S | Articolo su rivista | |
| 1-gen-2007 | The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR alpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study | Baccarani, M; Cilloni, D; Rondoni, M; Ottaviani, E; Messa, F; Merante, S; Tiribelli, M; Buccisano, F; Testoni, N; Gottardi, E; De Vivo, A; Giugliano, E; Iacobucci, I; Paolini, S; Soverini, S; Rosti, G; Rancati, F; Astolfi, C; Pane, F; Saglio, G; Martinelli, G | Articolo su rivista | |
| 1-gen-2008 | Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. | Gattei, V; Bulian, P; DEL PRINCIPE, Mi; Zucchetto, A; Maurillo, L; Buccisano, F; Bomben, R; Dal Bo, M; Luciano, F; Rossi, F; Degan, M; Amadori, S; DEL POETA, G | Articolo su rivista | |
| 1-gen-2008 | Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. | DEL POETA, G; DEL PRINCIPE, Mi; Buccisano, F; Maurillo, L; Capelli, G; Luciano, F; Perrotti, A; Degan, M; Venditti, A; DE FABRITIIS, P; Gattei, V; Amadori, S | Articolo su rivista | |
| 1-gen-2008 | SEQUENTIAL THERAPY WITH VAD, BORTEZOMIB AND CYCLOPHOSPHAMIDE AS INDUCTION THERAPY FOR MULTIPLE MYELOMA: A SEQUENTIAL PHARMACOLOGIC COMBINATION TO ACHIEVE COMPLETE REMISSIONS BEFORE STEM CELL TRANSPLANTATION | Postorino, M; Pupo, L; Di Caprio, L; Campagna, S; Franceschini, L; Renzi, D; Rizzo, M; Gianni, L; Faccia, S; Cannarsa, R; Ales, M; Buccisano, F; Venditti, D; Cantonetti, M; Amadori, S | Intervento a convegno | |
| 1-gen-2008 | Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia. | Stasi, R; Evangelista, M; Buccisano, F; Venditti, A; Amadori, S | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile